Antimicrobial Susceptibilities of Clinical Desulfovibrio Isolates
Overview
Authors
Affiliations
The antimicrobial susceptibilities of 16 clinical isolates of Desulfovibrio spp. were determined. All or most isolates were susceptible to imipenem (MIC(90) [MIC at which 90% of the isolates tested were inhibited], 0.5 microg/ml), metronidazole (MIC(90), 0.25 microg/ml), clindamycin (MIC(90), 4 microg/ml), and chloramphenicol (MIC(90), 16 microg/ml) but were resistant or intermediate to penicillin G (MIC(90), 64 microg/ml), piperacillin (MIC(90), 256 microg/ml), piperacillin-tazobactam (MIC(90), 256 microg/ml), cefoxitin (MIC(90), >256 microg/ml), and cefotetan (MIC(90), 64 microg/ml). Among isolates with decreased susceptibility to beta-lactams (n = 15), only six were beta-lactamase positive and susceptible to amoxicillin-clavulanate and ticarcillin-clavulanate.
Diversity and Comparison of Intestinal in Patients with Liver Cirrhosis and Healthy People.
Lu G, Zhang Y, Ren Y, Shi J, Xu Z, Geng Y Microorganisms. 2023; 11(2).
PMID: 36838242 PMC: 9960842. DOI: 10.3390/microorganisms11020276.
First case of bacteraemia successfully identified using MALDI-TOF MS.
Nasreddine R, Argudin M, Herpol M, Miendje Deyi V, Dauby N New Microbes New Infect. 2019; 32:100614.
PMID: 31763046 PMC: 6859274. DOI: 10.1016/j.nmni.2019.100614.
A Case of Liver Abscess with Desulfovibrio desulfuricans Bacteremia.
Koyano S, Tatsuno K, Okazaki M, Ohkusu K, Sasaki T, Saito R Case Rep Infect Dis. 2015; 2015:354168.
PMID: 25632357 PMC: 4302366. DOI: 10.1155/2015/354168.
Verstreken I, Laleman W, Wauters G, Verhaegen J J Clin Microbiol. 2011; 50(1):199-201.
PMID: 22075582 PMC: 3256723. DOI: 10.1128/JCM.00987-11.
Susceptibilities of 23 Desulfovibrio isolates from humans.
Nakao K, Tanaka K, Ichiishi S, Mikamo H, Shibata T, Watanabe K Antimicrob Agents Chemother. 2009; 53(12):5308-11.
PMID: 19786606 PMC: 2786338. DOI: 10.1128/AAC.00630-09.